Generic Versions of Biologics: The Problem and a Possible Solution By Paul F. Prestia This article is reprinted with permission from The Legal Intelligencer. © 2008 ALM Properties Inc. Further duplication without permis - The Legal Intelligencer - Document - PDFSEARCH.IO

First Page	Meta Content
	Generic Versions of Biologics: The Problem and a Possible Solution By Paul F. Prestia This article is reprinted with permission from The Legal Intelligencer. © 2008 ALM Properties Inc. Further duplication without permis Add to Reading List Document Date: 2013-03-31 19:00:47 Open Document File Size: 54,92 KB Share Result on Facebook Company ALM Properties Inc. / / Continent Europe / / Country United States / / Event FDA Phase / / Facility Court of Appeals for the Federal Circuit / / IndustryTerm biological tools / follow-on product / auxiliary new drug applications / biologic pharmaceuticals / follow-on biologic pharmaceuticals / pharmaceutical / intellectual property law / Present case law / patent law reform / manufacturing process / / Organization FDA / Congress / Court of Appeals / / Person Paul F. Prestia / / Product Europe / / Technology drug development / / SocialTag Pharmaceuticals policy Pharmaceutical industry Biosimilar Biotechnology Drugs Biologic Drug Price Competition and Patent Term Restoration Act Generic drug Abbreviated New Drug Application Pharmaceutical sciences

Generic Versions of Biologics: The Problem and a Possible Solution By Paul F. Prestia This article is reprinted with permission from The Legal Intelligencer. © 2008 ALM Properties Inc. Further duplication without permisAdd to Reading List